Cargando…

Gr1(−/low)CD11b(−/low)MHCII(+) myeloid cells boost T cell anti‐tumor efficacy

Conventional APCs that express MHC class II (MHCII) and co‐stimulatory molecules include dendritic cells (DCs) and macrophages. Beyond these conventional APCs, immune stimulatory cells have been more recently shown to extend to a class of atypical APCs, composed of mast cells, basophils, and eosinop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Payne, Kyle K., Aqbi, Hussein F., Butler, Savannah E., Graham, Laura, Keim, Rebecca C., Wan, Wen, Idowu, Michael O., Bear, Harry D., Wang, Xiang‐Yang, Manjili, Masoud H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Translational & Clinical Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258302/ https://www.ncbi.nlm.nih.gov/pubmed/29985529 http://dx.doi.org/10.1002/JLB.5A0717-276RR

Ejemplares similares

Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells
por: Payne, Kyle K., et al.
Publicado: (2016)

Autophagy-deficient breast cancer shows early tumor recurrence and escape from dormancy
por: Aqbi, Hussein F., et al.
Publicado: (2018)

Peripheral blood mononuclear cells of breast cancer patients can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells
por: Payne, Kyle K, et al.
Publicado: (2013)

Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsets
por: Aqbi, Hussein F., et al.
Publicado: (2020)

The crosstalking immune cells network creates a collective function beyond the function of each cellular constituent during the progression of hepatocellular carcinoma
por: Koelsch, Nicholas, et al.
Publicado: (2023)

HLA-DR expression on myeloid cells is a potential prognostic factor in patients with high-risk neuroblastoma
por: Gowda, Madhu, et al.
Publicado: (2013)

Characterization of CD4+ T cells primed and boosted by MHCII primary uveal melanoma cell-based vaccines
por: Kittler, Julia M., et al.
Publicado: (2019)

Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems
por: Manjili, Masoud H., et al.
Publicado: (2012)

HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus
por: Page, Nicolas, et al.
Publicado: (2010)

Restoration of CD4(+) T Cells during NAFLD without Modulation of the Hepatic Immunological Pattern Is Not Sufficient to Prevent HCC
por: Isbell, Madison, et al.
Publicado: (2022)

Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure
por: Kmieciak, Maciej, et al.
Publicado: (2011)

SOCS3 Suppression Promoted the Recruitment of CD11b(+)Gr-1(−)F4/80(−)MHCII(−) Early-Stage Myeloid-Derived Suppressor Cells and Accelerated Interleukin-6-Related Tumor Invasion via Affecting Myeloid Differentiation in Breast Cancer
por: Zhang, Wenwen, et al.
Publicado: (2018)

Evolution of Our Understanding of Myeloid Regulatory Cells: From MDSCs to Mregs
por: Manjili, Masoud H., et al.
Publicado: (2014)

Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma
por: Mirshahi, Faridoddin, et al.
Publicado: (2022)

IFN-γ Rα Is a Key Determinant of CD8+ T Cell-Mediated Tumor Elimination or Tumor Escape and Relapse in FVB Mouse
por: Kmieciak, Maciej, et al.
Publicado: (2013)

Granulocytic Myeloid-Derived Suppressor Cells (GR-MDSC) in Breast Milk (BM); GR-MDSC Accumulate in Human BM and Modulate T-Cell and Monocyte Function
por: Köstlin, Natascha, et al.
Publicado: (2018)

Mast cells acquire MHCII from dendritic cells during skin inflammation
por: Dudeck, Jan, et al.
Publicado: (2017)

Calcineurin-mediated IL-2 production by CD11c(high)MHCII(+) myeloid cells is crucial for intestinal immune homeostasis
por: Mencarelli, Andrea, et al.
Publicado: (2018)

Monomeric agonist peptide/MHCII complexes activate T‐cells in an autonomous fashion
por: Platzer, René, et al.
Publicado: (2023)

Coordinated Upregulation of Mitochondrial Biogenesis and Autophagy in Breast Cancer Cells: The Role of Dynamin Related Protein-1 and Implication for Breast Cancer Treatment
por: Zou, Peng, et al.
Publicado: (2016)

Characterization of splenic MRC1(hi)MHCII(lo) and MRC1(lo)MHCII(hi) cells from the monocyte/macrophage lineage of White Leghorn chickens
por: Yu, Keesun, et al.
Publicado: (2020)

Fate of MHCII in salmonids following 4WGD
por: Grimholt, Unni, et al.
Publicado: (2020)

Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function
por: Kmieciak, Maciej, et al.
Publicado: (2009)

MHCII expression on gut macrophages supports T cell homeostasis and is regulated by microbiota and ontogeny
por: Guillaume, Joël, et al.
Publicado: (2023)

Bone marrow-derived mesenchymal stromal cells promote colorectal cancer cell death under low-dose irradiation
por: Feng, Hao, et al.
Publicado: (2018)

The adaptation model of immunity: Is the goal of central tolerance to eliminate defective T cells or self‐reactive T cells?
por: Manjili, Masoud H.
Publicado: (2022)

Targeting Myeloid-Derived Suppressor Cells for Premetastatic Niche Disruption After Tumor Resection
por: Tang, Fan, et al.
Publicado: (2020)

MARCH1-mediated MHCII ubiquitination promotes dendritic cell selection of natural regulatory T cells
por: Oh, Jaehak, et al.
Publicado: (2013)

GR Dimerization and the Impact of GR Dimerization on GR Protein Stability and Half-Life
por: Louw, Ann
Publicado: (2019)

Germinal center entry not selection of B cells is controlled by peptide-MHCII complex density
por: Yeh, Chen-Hao, et al.
Publicado: (2018)

A universal MHCII technology platform to characterize antigen-specific CD4(+) T cells
por: Vyasamneni, Rohit, et al.
Publicado: (2023)

TREM2 mediates MHCII-associated CD4(+) T cell response against gliomas
por: Zheng, Jiaying, et al.
Publicado: (2023)

Low stromal Foxp3(+) regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
por: McCoy, M J, et al.
Publicado: (2015)

Iron Overload Mimicking Conditions Skews Bone Marrow Dendritic Cells Differentiation into MHCII(low)CD11c(+)CD11b(+)F4/80(+) Cells
por: Verna, Giulio, et al.
Publicado: (2020)

Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells
por: Shaikh, Haroon, et al.
Publicado: (2022)

MHCII glycosylation modulates Bacteroides fragilis carbohydrate antigen presentation
por: Ryan, Sean O., et al.
Publicado: (2011)

How MHCII signaling promotes benign host-microbiota interactions
por: Roland, Mary Melissa, et al.
Publicado: (2020)

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
por: Payne, Kyle K., et al.
Publicado: (2012)

Gr-1(+)CD11b(+) Myeloid-Derived Suppressor Cells: Formidable Partners in Tumor Metastasis
por: Yang, Li, et al.
Publicado: (2010)

Gr1(int)CD11b(+) Myeloid-Derived Suppressor Cells in Mycobacterium tuberculosis Infection
por: Obregón-Henao, Andrés, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4p75gpi84s2cj1vf5udei8qjks